Search

Your search keyword '"Bourdin, Arnaud"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Bourdin, Arnaud" Remove constraint Author: "Bourdin, Arnaud" Publication Type Magazines Remove constraint Publication Type: Magazines
53 results on '"Bourdin, Arnaud"'

Search Results

1. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

2. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort

3. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective

4. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

5. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

6. Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma

10. Non-typeable Haemophilus influenzae–Moraxella catarrhalisvaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial

11. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma

12. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

13. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

14. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma

15. Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma

16. Phenotyping of Severe Asthma in the Era of Broad-acting Anti-asthma Biologics

17. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C

18. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

19. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

20. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

21. International Severe Asthma Registry

23. The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database

24. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

25. Heat-moulded versus custom-made mandibular advancement devices for obstructive sleep apnoea: a randomised non-inferiority trial

27. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in PracticeSubstudy

28. Impact of initiatinGbioLogics In patients with severe asThma on long-Term OCS or frEquent Rescue steroids (GLITTER): data from the International Severe Asthma Registry

29. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

30. Les biomarqueurs dans l’asthme

31. Mucus from human bronchial epithelial cultures: rheology and adhesion across length scales

32. Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon)

33. Construction d’un épithélium bronchique innervé à partir de cellules souches pluripotentes induites iPSC

34. Supplementing Defect in Club Cell Secretory Protein Attenuates Airway Inflammation in COPD

35. Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies

36. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

38. Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases

39. Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease–related Interstitial Lung Diseases

40. Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases

41. Donor Clara Cell Secretory Protein Polymorphism is a Risk Factor for Bronchiolitis Obliterans Syndrome After Lung Transplantation

42. Limited Short-term Steroid Responsiveness Is Associated With Thickening of Bronchial Basement Membrane in Severe Asthma

43. Multicytokine Detection Improves Latent Tuberculosis Diagnosis in Health Care Workers

44. Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

45. Potential Severe Asthma Hidden in UK Primary Care

46. Étude vie réelle multicentrique des réglages de la ventilation auto-asservie : faire attention aux volumes générés !

47. Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

48. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

50. Identifier et prendre en charge l’asthme difficile

Catalog

Books, media, physical & digital resources